Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Editorial

Michael S Ewer et al. J Clin Oncol. 2008.

. 2008 Mar 10;26(8):1201-3.

doi: 10.1200/JCO.2007.14.8742. Epub 2008 Jan 28.

No abstract available

Comment on

Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.
Ganz PA, Hussey MA, Moinpour CM, Unger JM, Hutchins LF, Dakhil SR, Giguere JK, Goodwin JW, Martino S, Albain KS. Ganz PA, et al. J Clin Oncol. 2008 Mar 10;26(8):1223-30. doi: 10.1200/JCO.2007.11.8877. Epub 2008 Jan 28. J Clin Oncol. 2008. PMID: 18227530 Clinical Trial.
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. Perez EA, et al. J Clin Oncol. 2008 Mar 10;26(8):1231-8. doi: 10.1200/JCO.2007.13.5467. Epub 2008 Feb 4. J Clin Oncol. 2008. PMID: 18250349 Free PMC article. Clinical Trial.